Forward Citations = 862

Loading Chart...

8 inventors (with patents filed for the assignee):

Larry Richard Brown (4 out of 32 patents)

Terrence L Scott (4 out of 10 patents)

Charles D Blizzard (4 out of 4 patents)

4. James E Woiszwillo (3 out of 13 patents)

5. Frank J Riske (3 out of 4 patents)

6. Judith Sudhalter (3 out of 3 patents)

7. Jie Di (3 out of 4 patents)

8. Julia E Rashba-Step (1 out of 4 patents)

4 patents: Sort by Forward Citations

1. 6458387 - Sustained release microspheres (2002-10-01),

2. 6268053 - Macromolecular microparticles and methods of production and use (2001-07-31),

3. 6090925 - Macromolecular microparticles and methods of production and use (2000-07-18),

4. 5981719 - Macromolecular microparticles and methods of production and use (1999-11-09),

Company Overview

Epic Therapeutics, Inc. is a leading pharmaceutical company focused on developing innovative therapies for chronic diseases. With a strong emphasis on research and development, our team is dedicated to improving the lives of patients worldwide. Our cutting-edge treatments and commitment to excellence set us apart in the healthcare industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#31 in Norwood, MA

#3,314 in Massachusetts

#60,671 in US

Norwood, MA, United States of America

Epic Therapeutics, Inc.

Forward Citations = 862

8 inventors:

Larry Richard Brown (4 out of 32 patents)

Terrence L Scott (4 out of 10 patents)

Charles D Blizzard (4 out of 4 patents)

4. James E Woiszwillo (3 out of 13 patents)

5. Frank J Riske (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Epic Therapeutics, Inc.. Retrieved from https://idiyas.com/company/epic-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]